110 institutions hold shares in Clover Health Investments Corp. (CLOV), with 10.71M shares held by insiders accounting for 24.84% while institutional investors hold 17.56% of the company’s shares. The shares outstanding are 103.50M, and float is at 86.67M with Short Float at 34.18%. Institutions hold 13.20% of the Float.
Clover Health Investments Corp. (NASDAQ: CLOV) is -55.99% lower on its value in year-to-date trading and has touched a low of $6.31 and a high of $17.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLOV stock was last observed hovering at around $7.56 in the last trading session, with the day’s loss setting it -0.18% off its average median price target of $14.00 for the next 12 months. It is also 50.8% off the consensus price target high of $15.00 offered by 4 analysts, but current levels are 26.2% higher than the price target low of $10.00 for the same period.
Currently trading at $7.38, the stock is -8.78% and -29.93% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.2 million and changing -2.38% at the moment leaves the stock -33.77% off its SMA200. CLOV registered a loss of -40.77% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $8.85 and a 200-day simple moving average (SMA200) of $11.25.
The stock witnessed a -10.98% gain in the last 1 month and extending the period to 3 months gives it a -53.87%, and is -5.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.12% over the week and 9.26% over the month.
Distance from 52-week low is 16.96% and -57.71% from its 52-week high.
Clover Health Investments Corp. (CLOV) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Clover Health Investments Corp. (CLOV) is a “Overweight”. 4 analysts offering their recommendations for the stock have an average rating of 2.00, where 2 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Clover Health Investments Corp. is expected to release its quarterly report on 09/01/2021 and quarterly earnings per share for the current quarter are estimated at -$0.84 with sales reaching $166.23M over the same period.